OR WAIT null SECS
October 04, 2021
Will feature laboratories intended for R&D
September 28, 2021
Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers
September 27, 2021
Development of additional 29,000 square feet addresses med tech company’s internal production capabilities
Recent FDA actions may finally usher in access boost to follow-on biologics in the US
September 24, 2021
R&D partnership with VaxEquity outlines plan to use saRNA as a go-to therapeutic
September 16, 2021
Availability of space for new labs is a key selling point
September 15, 2021
Acquisition expected to help provide customers with a quicker clinical trial recruitment process
Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot
September 13, 2021
Latest construction plan continues CDMO’s vision for biopharma expansion
September 09, 2021
Collaboration earns Adaptimmune an initial payday of $150 million